Group 1: Conjugated linoleic acid (CLA)- capsule containing 0.5 g of 80% CLA (50:50 cis-9, trans-11 and trans-10,cis-12 isomers)

2 trials

Sponsors

Department of Pediatric Gastroenterology and Metabolic DiseasesPoznan University of Medical Sciences

Conditions

E66I70 E66

Unknown Phase

Metabolic consequences of conjugated linoleic acid supplementation in overweight and obese subjects.

Active, not recruitingDRKS00010462

Department of Pediatric Gastroenterology and Metabolic DiseasesPoznan University of Medical SciencesE66

Start: 2014-07-15Target: 74Updated: 2025-04-07

The effect of twelve week conjugated linoleic acid (CLA) supplementation on selected markers of atherosclerosis in obese and overweight women.

Active, not recruitingDRKS00010469

Department of Pediatric Gastroenterology and Metabolic DiseasesPoznan University of Medical SciencesI70 E66

Start: 2014-07-25Target: 74Updated: 2025-04-07

Related Papers

Psychological determinants of the effectiveness of conjugated linoleic acid supplementation in overweight and obese women—a randomized controlled trial

Frontiers in Nutrition2024-07-191 citations

The Effect of Conjugated Linoleic Acid Supplementation on Densitometric Parameters in Overweight and Obese Women—A Randomised Controlled Trial

Medicina2023-09-217 citations